Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
Dodick
David W
DW
Department of Neurology, Mayo Clinic Arizona, 5777 E. Mayo Blvd., Phoenix, AZ 85054, USA. Dodick.David@mayo.edu
Kost
James
J
Assaid
Christopher
C
Lines
Christopher
C
Ho
Tony W
TW